Establishing the Safe Space via Physiologically Based Biopharmaceutics Modeling. Case Study: Fevipiprant/QAW039

Post time 2024-6-17 01:31:42

journal：The AAPS Journal

Authors：Alexandros Kourentas; Monika Gajewska; Wen Lin; Sundeep S. Dhareshwar; Caroline Steib-Lauer; Swarupa Kulkarni; Stefan Hirsch; Tycho Heimbach; Martin Mueller-Zsigmondy

Published date：--

DOI：10.1208/s12248-023-00787-5

PDF link：https://link.springer.com/conten ... 248-023-00787-5.pdf

Article link：http://dx.doi.org/10.1208/s12248-023-00787-5

Article Source：Springer Science and Business Media LLC。

Remark：

Post time 2024-6-17 01:31:43

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Other] Establishing the Safe Space via Physiologically Based Biopharmaceutics Modeling. Case Study: Fevipiprant/QAW039

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Other] Establishing the Safe Space via Physiologically Based Biopharmaceutics Modeling. Case Study: Fevipiprant/QAW039 Copy